Literature DB >> 10070636

Selecting subjects for participation in clinical research: one sphere of justice.

C Weijer1.   

Abstract

Recent guidelines from the US National Institutes of Health (NIH) mandate the inclusion of adequate numbers of women in clinical trials. Ought such standards to apply internationally? Walzer's theory of justice is brought to bear on the problem, the first use of the theory in research ethics, and it argues for broad application of the principle of adequate representation. A number of practical conclusions for research ethics committees (RECs) are outlined. Eligibility criteria in clinical trials ought to be justified by trial designers. Research ethics committees ought to question criteria that seem to exclude unnecessarily women from research participation. The issue of adequate representation should be construed broadly, so as to include consideration of the representation of the elderly, persons with HIV, mental illness and substance abuse disorders in clinical research.

Entities:  

Keywords:  Analytical Approach; Biomedical and Behavioral Research; NIH Guidelines

Mesh:

Year:  1999        PMID: 10070636      PMCID: PMC479165          DOI: 10.1136/jme.25.1.31

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  12 in total

1.  Wanted. Single, white male for medical research.

Authors:  R Dresser
Journal:  Hastings Cent Rep       Date:  1992 Jan-Feb       Impact factor: 2.683

2.  Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria.

Authors:  S Yusuf; P Held; K K Teo; E R Toretsky
Journal:  Stat Med       Date:  1990 Jan-Feb       Impact factor: 2.373

3.  Differences in the use of procedures between women and men hospitalized for coronary heart disease.

Authors:  J Z Ayanian; A M Epstein
Journal:  N Engl J Med       Date:  1991-07-25       Impact factor: 91.245

4.  Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators.

Authors:  R M Steingart; M Packer; P Hamm; M E Coglianese; B Gersh; E M Geltman; J Sollano; S Katz; L Moyé; L L Basta
Journal:  N Engl J Med       Date:  1991-07-25       Impact factor: 91.245

5.  Eligibility and extrapolation in cancer clinical trials.

Authors:  C B Begg; P F Engstrom
Journal:  J Clin Oncol       Date:  1987-06       Impact factor: 44.544

6.  The eligibility of women for clinical research trials.

Authors:  W B Patterson; E J Emanuel
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

7.  The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care.

Authors:  L Bero; D Rennie
Journal:  JAMA       Date:  1995-12-27       Impact factor: 56.272

8.  Exclusion of "noncompliant" individuals from clinical trials.

Authors:  J R Hughes
Journal:  Control Clin Trials       Date:  1993-04

9.  Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study.

Authors:  S Giovanazzi-Bannon; A Rademaker; G Lai; A B Benson
Journal:  J Clin Oncol       Date:  1994-11       Impact factor: 44.544

10.  Representation of older patients in cancer treatment trials.

Authors:  E L Trimble; C L Carter; D Cain; B Freidlin; R S Ungerleider; M A Friedman
Journal:  Cancer       Date:  1994-10-01       Impact factor: 6.860

View more
  5 in total

Review 1.  What are the effects of the fifth revision of the Declaration of Helsinki?

Authors:  S M Tollman; H Bastian; R Doll; L J Hirsch; H A Guess
Journal:  BMJ       Date:  2001-12-15

2.  Brief report on the experience of using proxy consent for incapacitated adults.

Authors:  S Mason; H Barrow; A Phillips; G Eddison; A Nelson; N Cullum; J Nixon
Journal:  J Med Ethics       Date:  2006-01       Impact factor: 2.903

3.  Decreased depression up to one year following CBSM+ intervention in depressed women with AIDS: the smart/EST women's project.

Authors:  Arthur Laperriere; Gail H Ironson; Michael H Antoni; Heidi Pomm; Deborah Jones; Mary Ishii; David Lydston; Peter Lawrence; Alison Grossman; Elizabeth Brondolo; Andrea Cassells; Jonathan N Tobin; Neil Schneiderman; Stephen M Weiss
Journal:  J Health Psychol       Date:  2005-03

4.  "Cold calling" in psychiatric follow up studies: is it justified?

Authors:  P Tyrer; H Seivewright; B Ferguson; T Johnson
Journal:  J Med Ethics       Date:  2003-08       Impact factor: 2.903

5.  Does random treatment assignment cause harm to research participants?

Authors:  Cary P Gross; Harlan M Krumholz; Gretchen Van Wye; Ezekiel J Emanuel; David Wendler
Journal:  PLoS Med       Date:  2006-06       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.